Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Baird Medical Investment Holdings Ltd maintains a gross margin of 82.11%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -131.29%, while the net margin is -142.71%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively BDMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, BDMD competes directly with industry leaders such as HYPR and TMCI. With a market capitalization of $109.44M, it holds a significant position in the sector. When comparing efficiency, BDMD's gross margin of 82.11% stands against HYPR's 53.77% and TMCI's 80.79%. Such benchmarking helps identify whether Baird Medical Investment Holdings Ltd is trading at a premium or discount relative to its financial performance.
